Biotech and Breakthroughs in Immuno-Oncology

被引：0
|
作者：
Bockman, Jeffrey M. [1 ]
机构：
[1] Cello Hlth Bio Consulting, 25-B Hanover Rd,Suite 320, Florham Pk, NJ 07932 USA
来源：
UROLOGIC CLINICS OF NORTH AMERICA | 2020年 / 47卷 / 04期
关键词：
Immunotherapy; Immuno-oncology; Checkpoint inhibitors; Tumor microenvironment; Urologic oncology;
D O I：
10.1016/j.ucl.2020.07.006
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The age of immuno-oncology has ushered in a rush within the biopharmaceutical industry. This intense focus has been characterized as a frenzy or overhyped, but represents a substantial investment in new products that hope to harness the immune system against cancer. Such agents include next-generation checkpoint antagonists, immune costimulatory agonists, and a diverse array of novel mechanisms of action and therapeutic modalities targeting immune cell types and the interplay of the host and tumor at the immune synapse. This article surveys the clinical development and investment activity with Immuno-Oncology, specifically prostate, kidney, and bladder cancers. © 2020 Elsevier Inc.
引用
收藏
页码：511 / 521
页数：11
相关论文
共 50 条
  • [41] Immuno-Oncology in Cancer Care is a Fantastic Opportunity for Interventional Oncology: IO4IO (Interventional Oncology for Immuno-Oncology) Initiative
    de Baere, Thierry
    Tselikas, Lambros
    Deschamps, Frederic
    Soria, Jean Charles
    Marabelle, Aurelien
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 41 (06) : 825 - 827
  • [42] Introduction to the Special Issue: Immuno-oncology
    Anderson, Ana C.
    Kuchroo, Vijay K.
    [J]. SEMINARS IN IMMUNOLOGY, 2021, 52
  • [43] CRISPR technology for immuno-oncology applications
    Wang, Jianbin
    Balan, Vitaly
    Marincola, Francesco
    [J]. TUMOR IMMUNOLOGY AND IMMUNOTHERAPY - INTEGRATED METHODS, PT A, 2020, 635 : 251 - 266
  • [44] Immune monitoring for immuno-oncology applications
    Chattopadhyay, Pratip K.
    Lomas, Woodrow E.
    Gao, Guo-Jian
    Li, Na
    Saksena, Suraj
    [J]. JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [45] Nanomedicine and macroscale materials in immuno-oncology
    Sun, Qingxue
    Barz, Matthias
    De Geest, Bruno G.
    Diken, Mustafa
    Hennink, Wim E.
    Kiessling, Fabian
    Lammers, Twan
    Shi, Yang
    [J]. CHEMICAL SOCIETY REVIEWS, 2019, 48 (01) : 351 - 381
  • [46] Rescuing imperfect antigens for immuno-oncology
    Selena J. Lorrey
    Luis Sanchez-Perez
    Peter E. Fecci
    [J]. Nature Biotechnology, 2019, 37 : 1002 - 1003
  • [47] Assessing Treatment Benefit in Immuno-oncology
    Buyse, Marc
    Saad, Everardo D.
    Burzykowski, Tomasz
    Peron, Julien
    [J]. STATISTICS IN BIOSCIENCES, 2020, 12 (02) : 83 - 103
  • [48] Multiomic analysis of cytokines in immuno-oncology
    Jurisic, Vladimir
    [J]. EXPERT REVIEW OF PROTEOMICS, 2020, 17 (09) : 663 - 674
  • [49] Top 10 immuno-oncology collaborations
    Philippidis, Alex
    [J]. Genetic Engineering and Biotechnology News, 2019, 39 (05):
  • [50] Experimental animal modeling for immuno-oncology
    Li, Qi-Xiang
    Feuer, Gerold
    Ouyang, Xuesong
    An, Xiaoyu
    [J]. PHARMACOLOGY & THERAPEUTICS, 2017, 173 : 34 - 46
12345